Icon

JANUMET (nda022044)- (1GM;EQ 50MG BASE,500MG;EQ 50MG BASE)

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE MSD SUB MERCK
1GM;EQ 50MG BASE,500MG;EQ 50MG BASE
Yes Yes
2029-Jan-21 2011-Oct-16
None None
None No
JANUMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP- 4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
0 4 0
Total Other Developers 74
Drugs with Suitability No
1GM;EQ 50MG BASE ** ** Up - -
500MG;EQ 50MG BASE ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.